JSM 2012 Online Program
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Online Program HomeActivity Details
|
|||
390 * ! | Tue, 7/31/2012, 2:00 PM - 3:50 PM | CC-Room 25C | |
Clinical Trials: Some Recent Development on the Design and Statistical Analysis — Topic Contributed Papers | |||
Biopharmaceutical Section , International Indian Statistical Association | |||
Organizer(s): Yujun Wu, Sanofi | |||
Chair(s): Shailaja Suryawanshi, Merck | |||
2:05 PM | Maximizing the Role of Survival Post-Progression in Predicting Probability of Technical Success for Oncology Confirmatory Trials — Ke Zhang, Pfizer Inc. | ||
2:25 PM | Adaptive and Repeated Cumulative Meta-Analyses for Safety Signal Detection during a New Drug Development Process — Hui Quan, Sanofi ; Yingqiu Ma, Sanofi ; Yan Zheng, Sanofi ; Meehyung Cho, Sanofi | ||
2:45 PM | Application of Bayesian Probability of Success (POS) in Design of Vaccine Clinical Trials — Guanghan Liu, Merck Research Laboratories | ||
3:05 PM | Extension of Cure Rate Model When Cure Is Partially Known — Yu Wu, K&L Consulting Services, Inc. ; Yong Lin, University of Medicine and Dentistry of New Jersey ; Shou-En Lu, University of Medicine and Dentistry of New Jersey ; Weichung Joe Shih, University of Medicine and Dentistry of New Jersey | ||
3:25 PM | Statistical Considerations on Randomization Strategy, Drug Supply Strategy, and Other Trial Operational Factors — Xiaohong Huang, Sanofi Aventis ; Lixia Jiao, Sanofi Aventis ; Lynn Wei, Sanofi ; Hui Quan, Sanofi | ||
3:45 PM | Floor Discussion |
2012 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.